PanGen Biotech Financials
| 222110 Stock | KRW 6,000 290.00 4.61% |
PanGen |
Understanding current and past PanGen Biotech Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of PanGen Biotech's financial statements are interrelated, with each one affecting the others. For example, an increase in PanGen Biotech's assets may result in an increase in income on the income statement.
Please note, the presentation of PanGen Biotech's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, PanGen Biotech's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of PanGen Biotech's management manipulating its earnings.
PanGen Biotech Stock Summary
PanGen Biotech competes with Youngchang Chemical, Hyundai Home, Namhae Chemical, Cuckoo Homesys, and Sung Bo. PanGen Biotech Inc. operates as a specialized biologics company in South Korea. The company was founded in 1999 and is based in Suwon, South Korea. PanGen is traded on Korean Securities Dealers Automated Quotations in South Korea.| Instrument | Korea Stock View All |
| Exchange | KOSDAQ |
| ISIN | KR7222110009 |
| Business Address | Innoplex 2-dong, Suwon, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.pangen.com |
| Phone | 82 3 1733 9165 |
| Currency | KRW - South Korean Won |
You should never invest in PanGen Biotech without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of PanGen Stock, because this is throwing your money away. Analyzing the key information contained in PanGen Biotech's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
PanGen Biotech Key Financial Ratios
PanGen Biotech's financial ratios allow both analysts and investors to convert raw data from PanGen Biotech's financial statements into concise, actionable information that can be used to evaluate the performance of PanGen Biotech over time and compare it to other companies across industries.| Return On Equity | -24.89 | |||
| Return On Asset | -0.079 | |||
| Beta | 0.74 |
PanGen Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining PanGen Biotech's current stock value. Our valuation model uses many indicators to compare PanGen Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across PanGen Biotech competition to find correlations between indicators driving PanGen Biotech's intrinsic value. More Info.PanGen Biotech is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value PanGen Biotech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for PanGen Biotech's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.PanGen Biotech Systematic Risk
PanGen Biotech's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. PanGen Biotech volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on PanGen Biotech correlated with the market. If Beta is less than 0 PanGen Biotech generally moves in the opposite direction as compared to the market. If PanGen Biotech Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one PanGen Biotech is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of PanGen Biotech is generally in the same direction as the market. If Beta > 1 PanGen Biotech moves generally in the same direction as, but more than the movement of the benchmark.
PanGen Biotech November 28, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of PanGen Biotech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of PanGen Biotech. We use our internally-developed statistical techniques to arrive at the intrinsic value of PanGen Biotech based on widely used predictive technical indicators. In general, we focus on analyzing PanGen Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build PanGen Biotech's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.35 | |||
| Information Ratio | 0.1016 | |||
| Maximum Drawdown | 39.34 | |||
| Value At Risk | (6.10) | |||
| Potential Upside | 9.2 |
Complementary Tools for PanGen Stock analysis
When running PanGen Biotech's price analysis, check to measure PanGen Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PanGen Biotech is operating at the current time. Most of PanGen Biotech's value examination focuses on studying past and present price action to predict the probability of PanGen Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PanGen Biotech's price. Additionally, you may evaluate how the addition of PanGen Biotech to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |